In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2669-2676

  Shi, Lei ^a   Wang, Xiuli ^a   Zhao, Feng ^b   Luan, Hansen ^b   Tu, Qingfeng ^a   Huang, Zheng ^c   Wang, Hao ^b   Wang, Hongwei ^a,d  

^a Shanghai Skin Disease Hospital   (China)

^b National Pharmaceutical Engineering Research Center   (China)

^c FUJIAN NORMAL UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

5 Aminolevulinic acid (ALA); Nanoparticles; Photodynamic therapy (PDT); Poly(lactic co glycolic acid) (PLGA); Skin squamous cell carcinoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMINOLEVULINIC ACID; FLUORESCAMINE; NANOPARTICLE; POLYGLACTIN; PROTOPORPHYRIN;

ARTICLE; CARCINOMA CELL; CONCENTRATION RESPONSE; CYTOPLASM; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG EFFICACY; DRUG STRUCTURE; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOEMULSION; PARTICLE SIZE; PHOTODYNAMIC THERAPY; SKIN CARCINOMA; TREATMENT RESPONSE;

5-AMINOLEVULINIC ACID (ALA); NANOPARTICLES; PHOTODYNAMIC THERAPY (PDT); POLY(LACTIC-CO-GLYCOLIC ACID) (PLGA); SKIN SQUAMOUS CELL CARCINOMA;

AMINOLEVULINIC ACID; ANALYSIS OF VARIANCE; CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; KINETICS; LACTIC ACID; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYGLYCOLIC ACID;

EID: 84880758800     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S45821     Document Type: Article

References (30)

1. Huang Z, Xu H, Meyers AD, et al. Photodynamic therapy for treatment of solid tumors-potential and technical challenges. Technol Cancer Res Treat. 2008;7(4):309-320.
2. Wang XL, Wang HW, Wang HS, Xu SZ, Liao KH, Hillemanns P. Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. Br J Dermatol. 2004;151(4):880-885.
3. Babilas P, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology. Eur J Dermatol. 2006;16(4):340-348.
4. Wang XL, Wang HW, Guo MX, Xu SZ. Treatment of skin cancer and pre-cancer using topical ALA-PDT-a single hospital experience. Photodiagnosis Photodyn Ther. 2008;5(2):127-133.
5. Ishizuka M, Abe F, Sano Y, et al. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Int Immunopharmacol. 2011;11(3):358-365.
6. Wang H, Li J, Lv T, Tu Q, Huang Z, Wang X. Therapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless mice. Exp Dermatol. 2013;22(5):362-363.
7. Araújo LM, Thomazine JA, Lopez RF. Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy. Eur J Pharm Biopharm. 2010;75(1):48-55.
8. Ding H, Sumer BD, Kessinger CW, et al. Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX. J Control Release. 2011;151(3):271-277.
9. Yang SJ, Shieh MJ, Lin FH, et al. Colorectal cancer cell detection by 5-aminolaevulinic acid-loaded chitosan nano-particles. Cancer Lett. 2009;273(2):210-220.
10. Ito S, Miyoshi N, Degraff WG, Nagashima K, Kirschenbaum LJ, Riesz P. Enhancement of 5-aminolevulinic acid-induced oxidative stress on two cancer cell lines by gold nanoparticles. Free Radic Res. 2009;43(12):1214-1224.
11. Oh EK, Jin SE, Kim JK, Park JS, Park Y, Kim CK. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy. Eur J Pharm Sci. 2011;44(1-2):149-157.
12. Lü JM, Wang X, Marin-Muller C, et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn. 2009;9(4):325-341.
13. Allison RR, Mota HC, Bagnato VS, Sibata CH. Bio-nanotechnology and photodynamic therapy-state of the art review. Photodiagnosis Photodyn Ther. 2008;5(1):19-28.
14. Korbelik M, Madiyalakan R, Woo T, Haddadi A. Antitumor efficacy of photodynamic therapy using novel nanoformulations of hypocrellin photosensitizer SL052. Photochem Photobiol. 2012;88(1):188-193.
15. Namjoshi S, Caccetta R, Edwards J, Benson HA. Liquid chromatography assay for 5-aminolevulinic acid: application to in vitro assessment of skin penetration via dermaportation. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;852(1-2):49-55.
16. Mondalek FG, Lawrence BJ, Kropp BP, et al. The incorporation of poly(lactic-co-glycolic) acid nanoparticles into porcine small intestinal submucosa biomaterials. Biomaterials. 2008;29(9):1159-1166.
17. Tomokuni K, Ichiba M, Hirai Y, Hasegawa T. Optimized liquid-chromatographic method for fluorometric determination of urinary delta-aminolevulinic acid in workers exposed to lead. Clin Chem. 1987;33(9):1665-1667.
18. Oishi H, Nomiyama H, Nomiyama K, Tomokuni K. Fluorometric HPLC determination of delta-aminolevulinic acid (ALA) in the plasma and urine of lead workers: biological indicators of lead exposure. J Anal Toxicol. 1996;20(2):106-110.
19. Giuntini F, Bourré L, Macrobert AJ, Wilson M, Eggleston IM. Quantitative determination of 5-aminolaevulinic acid and its esters in cell lysates by HPLC-fluorescence. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;875(2):562-566.
20. Donnelly RF, Morrow DI, McCarron PA, et al. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J Control Release. 2008;129(3): 154-162.
21. Morrow DI, McCarron PA, Woolfson AD, et al. Novel patch-based systems for the localised delivery of ALA-esters. J Photochem Photobiol B. 2010;101(1):59-69.
22. Merclin N, Bender J, Sparr E, Guy RH, Ehrsson H, Engström S. Transdermal delivery from a lipid sponge phase-iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester. J Control Release. 2004;100(2):191-198.
23. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82(1):105-114.
24. Paszko E, Ehrhardt C, Senge MO, Kelleher DP, Reynolds JV. Nanodrug applications in photodynamic therapy. Photodiagnosis Photodyn Ther. 2011;8(1):14-29.
25. Lang K, Bolsen K, Stahl W, et al. The 5-aminolevulinic acid-induced porphyrin biosynthesis in benign and malignant cells of the skin. J Photochem Photobiol B. 2001;65(1):29-34.
26. Chung CW, Kim CH, Choi KH, et al. Effect of surfactant on 5-aminolevulinic acid uptake and PpIX generation in human cholangiocarcinoma cell. Eur J Pharm Biopharm. 2012;80(2):453-458.
27. Rud E, Gederaas O, Høgset A, Berg K. 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol. 2000;71(5):640-647.
28. Fernando LP, Kandel PK, Yu J, McNeill J, Ackroyd PC, Christensen KA. Mechanism of cellular uptake of highly fluorescent conjugated polymer nanoparticles. Biomacromolecules. 2010;11(10):2675-2682.
29. Smith PJ, Giroud M, Wiggins HL, et al. Cellular entry of nanoparticles via serum sensitive clathrin-mediated endocytosis, and plasma membrane permeabilization. Int J Nanomedicine. 2012;7:2045-2055.
30. Wang Y, Guo M, Lu Y, et al. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Nanotechnology. 2012;23(49):495103.